Please use this identifier to cite or link to this item:
http://hdl.handle.net/10553/43065
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Henríquez-Hernández, Luis Alberto | |
dc.contributor.author | Murias-Rosales, Adolfo | |
dc.contributor.author | González-Hernández, Ana | |
dc.contributor.author | de León, Antonio Cabrera | |
dc.contributor.author | Díaz-Chico, Nicolás | |
dc.contributor.author | Fernández-Pérez, Leandro | |
dc.date.accessioned | 2018-11-21T12:19:56Z | - |
dc.date.available | 2018-11-21T12:19:56Z | - |
dc.date.issued | 2010 | |
dc.identifier.issn | 1877-7821 | |
dc.identifier.uri | http://hdl.handle.net/10553/43065 | - |
dc.description.abstract | Purpose To investigate the role of TSER (TYMS), C677T (MTHFR), Arg72Pro (p53) and C3435T (MDR1) gene polymorphisms in breast cancer patients treated with 5-fluorouracil and cyclophosphamide-based neoadjuvant chemotherapy. Results Observed allelic frequencies were: TSER, (2) 0.54 and (3) 0.46; MTHFR C677T, (C) 0.59 and (T) 0.41; p53 Arg72Pro, (Arg) 0.73 and (Pro) 0.27; MDR1 C3435T, (C) 0.52 and (T) 0.48. MTHFR allele T and p53 allele Pro were strongly associated with toxicity due to chemotherapy (odds ratio, 7.1 (95% confidence interval, 1.4-36.1; p = 0.018) and 7.0 (95% confidence interval, 1.2-40.5; p = 0.029), respectively). Conclusion We introduced new data related to the contribution of p53 codon 72 to toxicity due to 5-fluorouracil and cyclophosphamide-based neoadjuvant chemotherapy in patients with breast cancer. (C) 2010 Elsevier Ltd. All rights reserved. | |
dc.publisher | 1877-7821 | |
dc.relation.ispartof | Cancer Epidemiology | |
dc.source | Cancer Epidemiology[ISSN 1877-7821],v. 34, p. 634-638 | |
dc.subject.other | Acute Lymphoblastic-Leukemia | |
dc.subject.other | Methylenetetrahydrofolate Reductase C677T | |
dc.subject.other | Colorectal-Cancer | |
dc.subject.other | Thymidylate Synthase | |
dc.subject.other | Clinical-Practice | |
dc.subject.other | Ovarian-Cancer | |
dc.subject.other | In-Vivo | |
dc.subject.other | Toxicity | |
dc.subject.other | Pharmacogenomics | |
dc.subject.other | Therapy | |
dc.title | Distribution of TYMS, MTHFR, p53 and MDR1 gene polymorphisms in patients with breast cancer treated with neoadjuvant chemotherapy | |
dc.type | info:eu-repo/semantics/Article | es |
dc.type | Article | es |
dc.identifier.doi | 10.1016/j.canep.2010.06.013 | |
dc.identifier.scopus | 77957240834 | - |
dc.identifier.isi | 000283974700019 | |
dc.contributor.authorscopusid | 15829708200 | |
dc.contributor.authorscopusid | 6506456721 | |
dc.contributor.authorscopusid | 24921512000 | |
dc.contributor.authorscopusid | 7006344449 | |
dc.contributor.authorscopusid | 25723175700 | |
dc.contributor.authorscopusid | 6506777525 | |
dc.description.lastpage | 638 | |
dc.description.firstpage | 634 | |
dc.relation.volume | 34 | |
dc.type2 | Artículo | es |
dc.contributor.daisngid | 465624 | |
dc.contributor.daisngid | 8797852 | |
dc.contributor.daisngid | 17097957 | |
dc.contributor.daisngid | 14738520 | |
dc.contributor.daisngid | 1724161 | |
dc.contributor.daisngid | 795544 | |
dc.contributor.wosstandard | WOS:Henriquez-Hernandez, LA | |
dc.contributor.wosstandard | WOS:Murias-Rosales, A | |
dc.contributor.wosstandard | WOS:Gonzalez-Hernandez, A | |
dc.contributor.wosstandard | WOS:de Leon, AC | |
dc.contributor.wosstandard | WOS:Diaz-Chico, N | |
dc.contributor.wosstandard | WOS:Fernandez-Perez, L | |
dc.date.coverdate | Octubre 2010 | |
dc.identifier.ulpgc | Sí | es |
dc.description.jcr | 1,182 | |
dc.description.jcrq | Q4 | |
dc.description.scie | SCIE | |
item.grantfulltext | none | - |
item.fulltext | Sin texto completo | - |
crisitem.author.dept | GIR IUIBS: Medio Ambiente y Salud | - |
crisitem.author.dept | IU de Investigaciones Biomédicas y Sanitarias | - |
crisitem.author.dept | Departamento de Ciencias Clínicas | - |
crisitem.author.dept | GIR IUIBS: Bioquímica | - |
crisitem.author.dept | IU de Investigaciones Biomédicas y Sanitarias | - |
crisitem.author.dept | Departamento de Bioquímica y Biología Molecular, Fisiología, Genética e Inmunología | - |
crisitem.author.dept | GIR IUIBS: Farmacología Molecular y Traslacional | - |
crisitem.author.dept | IU de Investigaciones Biomédicas y Sanitarias | - |
crisitem.author.dept | Departamento de Ciencias Clínicas | - |
crisitem.author.orcid | 0000-0003-3237-0316 | - |
crisitem.author.orcid | 0000-0002-0944-990X | - |
crisitem.author.orcid | 0000-0001-7802-465X | - |
crisitem.author.parentorg | IU de Investigaciones Biomédicas y Sanitarias | - |
crisitem.author.parentorg | IU de Investigaciones Biomédicas y Sanitarias | - |
crisitem.author.parentorg | IU de Investigaciones Biomédicas y Sanitarias | - |
crisitem.author.fullName | Henríquez Hernández, Luis Alberto | - |
crisitem.author.fullName | Díaz Chico, Juan Carlos | - |
crisitem.author.fullName | Fernández Pérez, Leandro Francisco | - |
Appears in Collections: | Artículos |
SCOPUSTM
Citations
29
checked on Nov 17, 2024
WEB OF SCIENCETM
Citations
27
checked on Nov 17, 2024
Page view(s)
40
checked on Feb 10, 2024
Google ScholarTM
Check
Altmetric
Share
Export metadata
Items in accedaCRIS are protected by copyright, with all rights reserved, unless otherwise indicated.